Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndrome in Oncology Patients
NCT ID: NCT06508788
Last Updated: 2024-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2024-07-01
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to evaluate the effectiveness of vaginal laser together with adjuvant treatment with a hydrating and repairing niosomal gel as a beneficial treatment in this group of patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors
NCT06007027
Vaginal Laser Therapy in Breast Cancer Survivors
NCT03738605
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
NCT03372720
Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients
NCT03628092
Vaginal CO2 Laser and the Genitourinary Syndrome of Menopause
NCT03754205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CO2 laser cohort
Patients with a history of oncology and for whom a diagnosis of genitourinary syndrome is established and who are not eligible for treatment with hormonal therapy
CO2 laser
Application of CO2 vulvo-vaginal laser according to standard therapy and moisturizing gels
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CO2 laser
Application of CO2 vulvo-vaginal laser according to standard therapy and moisturizing gels
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a history of neoplasia in whom the use of estrogens as the first alternative for the treatment of GMS is not recommended.
Exclusion Criteria
* Patients with a diagnosis of pelvic organ prolapse grade II or greater.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitari de Bellvitge
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlos Ortega-Expósito
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Carlos
L'Hospitalet de Llobregat, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICPS010/24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.